Miguel Gil
Impact in
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 3
-
- Antiplatelet Therapy and Cardiovascular Diseases 9
- Atrial Fibrillation Management and Outcomes 3
- Co-authors
- Francisco J. de AbajoLuis A. García‐RodríguezVerónica BryantAntonio RodríguezSara Rodríguez‐MartínBelén OlivaEnrique GalveJordi Soler‐Soler
- Journals
- Pharmacoepidemiology and Drug Safety (5 papers)European Journal of Clinical Pharmacology (5 papers)Journal of Clinical Medicine (4 papers)Heart (2 papers)PLoS ONE (2 papers)
- Partner nations
- SpainJapanUnited States
In The Last Decade
Miguel Gil
34 papers receiving 628 citations
Peers
Comparison fields: 5 of 98
- Toxicology 49
- Geriatrics and Gerontology 47
- Pharmacology 119
- Cardiology and Cardiovascular Medicine 156
- Nephrology 47
Countries citing papers authored by Miguel Gil
This map shows the geographic impact of Miguel Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel Gil more than expected).
Fields of papers citing papers by Miguel Gil
This network shows the impact of papers produced by Miguel Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel Gil. The network helps show where Miguel Gil may publish in the future.
Co-authors
The 25 scholars most cited alongside Miguel Gil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2021 | 11 | |
| 4 | 2021 | 17 | |
| 5 | 2020 | 0 | |
| 6 | 2020 | 40 | |
| 7 | 2020 | 7 | |
| 8 | 2019 | 12 | |
| 9 | 2019 | 14 | |
| 10 | 2019 | 10 | |
| 11 | 2018 | 11 | |
| 12 | 2015 | 41 | |
| 13 | 2015 | 9 | |
| 14 | 2015 | 9 | |
| 15 | 2015 | 1 | |
| 16 | 2014 | 25 | |
| 17 | 2014 | 49 | |
| 18 | 2013 | 10 | |
| 19 | 2010 | 2 | |
| 20 | 1992 | 106 |
About Miguel Gil
Miguel Gil is a scholar working on Toxicology, Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology, Pharmacology and Pharmacology, having authored 37 papers that have together received 643 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Lipoproteins and Cardiovascular Health (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Inflammatory mediators and NSAID effects (5 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers), Vitamin D Research Studies (3 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). The work is most often cited by research in Toxicology (49 citations), Geriatrics and Gerontology (47 citations), Pharmacology (119 citations), Cardiology and Cardiovascular Medicine (156 citations) and Nephrology (47 citations). Miguel Gil has collaborated with scholars based in Spain, Japan and United States. Frequent co-authors include Francisco J. de Abajo, Luis A. García‐Rodríguez, Verónica Bryant, Antonio Rodríguez, Sara Rodríguez‐Martín, Belén Oliva, Enrique Galve, Jordi Soler‐Soler, M.P. Tornos and Montserrat Olona. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, European Journal of Clinical Pharmacology, Journal of Clinical Medicine, Heart and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.